SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001013762-24-003209
Filing Date
2024-07-31
Accepted
2024-07-31 16:05:22
Documents
14
Period of Report
2024-07-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0210326-8k_cadrenal.htm   iXBRL 8-K 44837
2 AMENDMENT TO THE CADRENAL THERAPEUTICS, INC. 2022 SUCCESSOR EQUITY INCENTIVE PLA ea021032601ex10-1_cadrenal.htm EX-10.1 9623
  Complete submission text file 0001013762-24-003209.txt   235043

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE cvkd-20240729.xsd EX-101.SCH 3015
4 XBRL LABEL FILE cvkd-20240729_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE cvkd-20240729_pre.xml EX-101.PRE 22359
16 EXTRACTED XBRL INSTANCE DOCUMENT ea0210326-8k_cadrenal_htm.xml XML 3799
Mailing Address 822 A1A NORTH SUITE 300 PONTE VEDRA FL 32082
Business Address 822 A1A NORTH SUITE 300 PONTE VEDRA FL 32082 904-300-0701
Cadrenal Therapeutics, Inc. (Filer) CIK: 0001937993 (see all company filings)

IRS No.: 880860746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41596 | Film No.: 241161889
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)